Recent PCRX Stock Price | PCRX Stock Predictions | |
$29.04 | +59.44% |
$46.30 |
Recent PCRX Analyst Ratings Breakdown, Making PCRX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 7 | 7 | 8 | 8 |
Buy ratings: | 3 | 3 | 3 | 3 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.3 | 1.3 | 1.27 | 1.27 |
For the PCRX stock predictions from the analysts covering Pacira BioSciences Inc, we have collected all of the individual PCRX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 10 different analysts covering PCRX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since PCRX stock predictions may vary widely, another useful metric to consider is the median PCRX stock prediction, which represents the price at which half of the analysts
made PCRX stock predictions that were higher and half made PCRX stock predictions that were lower. This makes for a different take on the PCRX stock predictions out there, as compared to average or mean.
And that median across all the individual PCRX stock predictions was: $45.0 as of 2024-03-28.
The very highest of the PCRX stock predictions for one year price target was $57.0, while the very lowest of the PCRX stock predictions in the analyst group was
$36.0 (with a standard deviation of $6.684). Get the latest Zacks research report on PCRX — FREE
Find out: PCRX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
IRWD Stock Predictions
NVUS Stock Predictions
NYCB Stock Predictions
MRSN Stock Predictions
EKSO Stock Predictions
FNF Stock Predictions
ALLY Stock Predictions
OMC Stock Predictions
PTC Stock Predictions
|
|
Strong Buy (3.70 out of 4) 70th percentile
(ranked higher than approx. 70% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |